Clinical Trial Update: Predicting Cancer Risk With Digital and Molecular Markers [NA]

View source ↗

Summary

A University of Erlangen-Nürnberg Medical School trial aims to predict cancer risk using digital and molecular markers across several cancer types. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gynecologic Cancer
• Lung Cancer

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Breast Cancer, Lung Cancer | NA | Status: RECRUITING